Stryker Receives Neutral Rating Amid "Strong Competition" — 5 Key Concepts

Spinal Tech

Stryker reported second quarter 2014 financial results earlier this month, and Zacks came out with a new research report on the company, according to a Digital Journal report.

Here are five things to know from the Zacks analysis:

 

1. Stryker missed the Zacks Consensus Estimate for second quarter adjusted earnings by $0.01, although the company did report a 1 percent increase year-over-year. The company's stock opened at $81.94 on July 22 and had a market cap of $31 billion, according to a Yahoo Finance report.

 

2. According to the financial report, the company expects 5 percent to 6 percent organic revenue growth this year, which is narrower than the range reported earlier — 4.5 percent to 6 percent. The company reported United States sales reaching $1.5 billion, but spine sales in the country were down 6.1 percent over the same period last year.

 

3. Despite the company's financial report, Zacks is concerned about "strong competition from Johnson & Johnson," as the medtech giant also reported a strong second quarter with orthopedic sales increasing 3.5 percent to $2.4 billion. The company's subsidiary, DePuy Synthes, recently partnered with Tissue Regeneration Systems as well to develop three-dimensional printing technologies.

 

4. Medtronic's recent acquisition of Covidien and Zimmer's merger with Biomet also pose a threat to Stryker's future as a major medtech company, according to the Zacks report. Stryker hasn't been completely out of the acquisition game; the company has made a few moves recently — the most notable being the MAKO Surgical acquisition last year and the Small Bone Innovations acquisition earlier this month — but no blockbuster moves that will have the same impact as Medtronic-Covidien or Zimmer-Biomet.

 

5. Zacks reiterated a "neutral" rating for Stryker and set a target price of $86 on the company's stock.

 

More Articles on Orthopedic Devices:
15 Spine Devices Receive FDA 510(k) Clearance in June
Titan Spine Receives Research Award From Scoliosis Research Society
Cayenne Medical Launches SureLock All-Suture Anchor System

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers